デフォルト表紙
市場調査レポート
商品コード
1331048

医薬品グレードの塩化ナトリウムの世界市場

Pharmaceutical Grade Sodium Chloride

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 179 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
医薬品グレードの塩化ナトリウムの世界市場
出版日: 2023年08月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医薬品グレードの塩化ナトリウムの世界市場は2030年までに8億7,840万米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に5億6,370万米ドルと予測された医薬品グレードの塩化ナトリウムの世界市場は、2030年までに8億7,840万米ドルに改定され、2022年から2030年にかけてCAGR 5.7%で成長すると予測されます。本レポートで分析されているセグメントの一つである透析は、CAGR6.1%を記録し、分析期間終了時には3億8,040万米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、注射分野の成長は今後8年間のCAGRを6.4%に修正しました。

米国市場は1億6,690万米ドルと推定、中国はCAGR 5.2%で成長すると予測

米国の医薬品グレードの塩化ナトリウム市場は、2022年には1億6,690万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 5.2%で推移し、2030年には1億5,150万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ4.9%と4.7%の成長が予測されています。欧州では、ドイツがCAGR約4.2%で成長すると予測されています。

調査対象企業の例

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co., Ltd.
  • K+S France S.A.S.
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co., Ltd.
  • US Salt, LLC.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP13957

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Pharmaceutical Grade Sodium Chloride Market to Reach $878.4 Million by 2030

In the changed post COVID-19 business landscape, the global market for Pharmaceutical Grade Sodium Chloride estimated at US$563.7 Million in the year 2022, is projected to reach a revised size of US$878.4 Million by 2030, growing at aCAGR of 5.7% over the period 2022-2030. Dialysis, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$380.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Injections segment is readjusted to a revised 6.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $166.9 Million, While China is Forecast to Grow at 5.2% CAGR

The Pharmaceutical Grade Sodium Chloride market in the U.S. is estimated at US$166.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$151.5 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 12 Featured) -

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co., Ltd.
  • K+S France S.A.S.
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co., Ltd.
  • US Salt, LLC.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Oral Rehydration Salts (ORS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Pharmaceutical Grade Sodium Chloride Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: China 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: France 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Rest of World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION